Agrinews24 কৃষির সাথে, কৃষকের পাশে
Staff Correspondent: A seminar titled ” Vaxxiknowledge-2025″ was held in Dhaka as a joint initiative of Renata and Vaxxinova. The seminar was organized on Monday (13th of January) evening at Le Meridien Hotel, capital city. The primary objective of this seminar was to address the challenges in managing Avian Influenza (H9N2), Newcastle Disease (ND), Infectious Bronchitis (IB) and Mycoplasmosis (MG) as well as the latest advancements in combating these diseases. Experts and senior officials of reputed poultry breeding farms of the country were present on the occasion.
Mr. Sirajul Hoque, Director, Renata Animal Division delivered opening speech on the occasion. He said, Renata PLC is one of the largest and fastest growing pharmaceutical companies in Bangladesh. One of our core businesses is animal health products. In the field of animal health, we have been the undisputed market leader in Bangladesh for the past 30 years. He said, without the support of all of you, Renata would not have reached this stage today. At this time, he expressed sincere thanks and gratitude to the guests.
Mr. Sirajul also informed that, Renata Animal Health Division is marketing poultry vaccines manufactured by Vaxxinova. Vaxxinova is a global leader in animal health and poultry vaccines.
Mr. Calvin Tan Regional Manager, Vaxxinova Asia Pacific gave welcome speech on the occasion. At this time, he gave a light brief about Vaxxinova. Vaxxinova US, originally called Epitopix, began as the laboratory service division of Willmar Poultry Company (WPC) in Willmar, Minnesota. During the 1980s, WPC began to seek innovative ways to improve the health of its turkey breeding stock.
“Through many years of research, our team developed ground-breaking technology in the form of Siderophore Receptor Protein (SRP) vaccines. This revolutionary vaccine immunizes against bacterial infections utilizing a cell-free purified extract of SRPs. By 1997, vaccine made from the combined SRP of Salmonella, E. coli, and P. multocida was in widespread use across the WPC breeder operations in Minnesota”- he added.
Mr. Julien Gros, Sales Director, International Zone, presented the article titled “Poultry vaccine trend and Vaxxinova vision” in the event. He reports a 40-years (1990-2030) study of global meat consumption, which shows that consumption of poultry meat, more than any other meat, continues to increase and will continue to increase. Since 2017, Poultry meat is the first source animal protein -he said. He also said – In addition to developed countries like Europe, America, Asia, even the neighboring India, the per capita consumption of poultry egg and meat in Bangladesh is still less.
Dr. Ludio Gomes, Technical Manager, Vaxxinova Asia Pacific, presented the article titled “Respiratory shield against IB, ND and H9N2 LPAI” in the event. He said, Co-circulation of H9N2 viruses may lead to silent spread of HPAI viruses due to partial heterologous protection against mortality. He also added, Vaccine are like a marriage you only see how strong it is once you give challenges.
Dr. Husam Bakri, Technical Manager and, Lab Director-MENA, presented the article titled “Critical points on Mycoplasma gallisepticum (MG) control” in the event.
Prof. Dr. Rokshana Parvin, Department of Pathology, Bangladesh Agricultural University, presented the article titled “Investigation of efficacy and safety of VAXXON AVIFLU and VAXXON ND-FLU in clinical trial” in the event. At this time, he presented the trial report of the mentioned two vaccines.
Dr. Himel Chakma, Group product manager, Renata PLC., played the role of moderator in the whole program. Moreover, Dr. Md. Zahid Hossain, country representative of Vaxxinova Bangladesh, senior officers of Renata were present on the occasion.
